Download Issue

Total Page:16

File Type:pdf, Size:1020Kb

Download Issue Cell Circuitry || Science Teaches English || The Chicken Genome Is Hot || Magnets in Medicine SEPTEMBER 2002 www.hhmi.org/bulletin Leading Doublea Life It’s a stretch, but doctors who work bench to bedside say they wouldn’t do it any other way. FEATURES 14 On Human Terms 24 The Evolutionary War A small—some say too small—group of Efforts to undermine evolution education have physician-scientists believes the best science evolved into a 21st-century marketing cam- requires patient contact. paign that relies on legal acumen, manipulation By Marlene Cimons of scientific literature and grassroots tactics. 20 Engineering the Cell By Trisha Gura Adam Arkin sees the cell as a mechanical system. He hopes to transform molecular 28 Call of the Wild biology into a kind of cellular engineering Could quirky, new animal models help scien- and in the process, learn how to move cells tists learn how to regenerate human limbs or from sickness to health. avert the debilitating effects of a stroke? By M. Mitchell Waldrop By Kathryn Brown 24 In front of a crowd of 1,500, Ohio’s Board of Education heard testimony on whether students should learn about intelligent design in science class. DEPARTMENTS 2 NOTA BENE 33 PERSPECTIVE ulletin Intelligent Design Is a Cop-Out 4 LETTERS September 2002 || Volume 15 Number 3 NEWS AND NOTES HHMI TRUSTEES PRESIDENT’S LETTER 5 JAMES A. BAKER, III, ESQ. 34 Senior Partner, Baker & Botts A Creative Influence In from the Fields ALEXANDER G. BEARN, M.D. Executive Officer, American Philosophical Society 35 Lost on the Tip of the Tongue Adjunct Professor, The Rockefeller University UP FRONT Professor Emeritus of Medicine, Cornell University Medical College 36 Biology by Numbers FRANK WILLIAM GAY 6 Follow the Songbird Former President and Chief Executive Officer, SUMMA Corporation JAMES H. GILLIAM, JR., ESQ. 8 Curriculum Congestion 37 Undergraduate Grants Foster Former Executive Vice President and General Counsel, Teaching, Interdisciplinary Beneficial Corporation HANNA H. GRAY, PH.D., C HAIRMAN 9 Learning from Their Elders Courses President Emeritus and Harry Pratt Judson Distinguished Service 11 Professor of History, The University of Chicago With a Little Help from 37 Students Love the Details GARNETT L. KEITH Chairman, SeaBridge Investment Advisors, L.L.C. Our Friends Former Vice Chairman and Chief Investment Officer, The Prudential 38 From Soybean Finding, Insurance Company of America 13 Q & A Genome Insider JEREMY R. KNOWLES, D.PHIL. a Career in Science Sprouts Dean of the Faculty of Arts and Sciences and Amory Houghton Professor of Chemistry and Biochemistry, Harvard University 39 WILLIAM R. LUMMIS, ESQ. HHMI Professors Promise Former Chairman of the Board of Directors to Break the Mold and Chief Executive Officer, The Howard Hughes Corporation ANNE M. TATLOCK Chairman and Chief Executive Officer Fiduciary Trust Company International 40 HHMI LAB BOOK HHMI OFFICERS THOMAS R. CECH, PH.D., President 42 HANDS ON PETER J. BRUNS, PH.D., Vice President for Animal Magnetism Grants and Special Programs DAVID A. CLAYTON, PH.D., Vice President and Chief Scientific Officer 44 INSIDE HHMI STEPHEN M. COHEN, Vice President and Chief Financial Officer International Scholars JOAN S. LEONARD, ESQ., Vice President and General Counsel AVICE A. MEEHAN, Vice President for Communications Down Under and Public Affairs GERALD M. RUBIN, PH.D., Vice President and 45 On Stage and Off, This Director of Planning for Janelia Farm Lawyer Performs NESTOR V. SANTIAGO, Vice President and Chief Investment Officer HHMI BULLETIN STAFF 14 On the Cover: Photographs by Kathleen Dooher. CORI VANCHIERI, Editor JIM KEELEY, Science Editor Jennifer Donovan, Education Editor 34 PATRICIA FOSTER, Manager of Publishing KIMBERLY BLANCHARD, Editorial Coordinator ELIZABETH COWLEY, Copy Editor Maya Pines, Contributing Editor KALYANI NARASIMHAN, fact checking STEVEN MARCUS, PETER TARR, story editing KATHY SAVORY, copy editing David Herbick Design, Publication Design Telephone (301) 215 8855 n Fax (301) 215 8863 n www.hhmi.org The Bulletin is published by the HHMI Office of Communications and Public Affairs. © 2002 Howard Hughes Medical Institute PRETE/AP (LEFT), DAVID GRAHAM (TOP RIGHT), TORSTEN KJELLSTRAND (BOTTOM RIGHT) A The opinions, beliefs and viewpoints expressed by authors in the HHMI Bulletin do not necessarily reflect the opinions, beliefs and viewpoints or JAY L official policies of the Howard Hughes Medical Institute. NOTA BENE tinction Award. The awards are given by ■ James P. Allison, hhmi investigator at the ■ hhmi President Emeritus Purnell W. panels of producers and other communica- University of California, Berkeley, won the Choppin received an honorary doctorate of tions professionals. 2002 Public Service Award from the Ameri- humane letters from The Johns Hopkins can Society of Immunologists and the 2001 University at its 2002 commencement. ■ H. Robert Horvitz, an hhmi investigator Centeon Award for Innovative Break- at the Massachusetts Institute of Technolo- throughs in Immunology. ■ The Royal Society, the United Kingdom’s gy,received the 2001 Genetics Society of national academy of science, named Roger J. America Medal. ■ Five hhmi investigators have been named Davis, an hhmi investigator at the Universi- fellows of the American Academy of Arts and ty of Massachusetts Medical School, one of ■ Andrzej Jerzmanowski, an hhmi interna- Sciences: David J. Anderson,California Insti- its 2002 fellows. Peter H. Raven, director of tional research scholar at Warsaw Univer- tute of Technology; Cornelia I. Bargmann, the Missouri Botanical Garden and pro- sity, has been elected to the Polish Academy Ronald D. Vale and Peter Walter,University of gram director of an hhmi precollege sci- of Sciences. California, San Francisco; and A. James Hud- ence education grant there, was elected a ■ speth,The Rockefeller University. foreign member of the society. Saulius Klimas˘auskas and Virginijus Siksnys, hhmi international research scholars in ■ ■ Three hhmi investigators and two of the Stephen J. Elledge, an hhmi investigator Lithuania, received the 2002 National Sci- Institute’s leaders were named as “Biotech at Baylor College of Medicine, won the 2002 ence Prize from the government of the Geniuses to Watch” in the June issue of National Academy of Sciences Award in Republic of Lithuania. Molecular Biology. The award recognizes a Discover magazine: David Baker,University young scientist who has made a recent ■ Louis M. Kunkel, an investigator at of Washington; Elaine Fuchs,who recently hhmi notable discovery in the field. Children’s Hospital, Boston, won the 2002 moved to The Rockefeller University; Stuart LIFE International Research Award for sci- L. Schreiber,Harvard University; Thomas R. ■ David Ginsburg, an hhmi investigator at entists whose research has led to clinical Cech, hhmi president; and Gerald M. Rubin, the University of Michigan Medical School, applications. The award is presented annu- vice president and director of planning for won the 2002 ISFP Prize from the Interna- ally by the Lois Pope LIFE Foundation. Janelia Farm. tional Society for Fibrinolysis and Proteolysis. ■ Two hhmi international research schol- ■ Nine hhmi investigators were elected to ■ Philip Green, an hhmi investigator at the ars, Pedro Labarca of Chile and Raúl A. Padrón the National Academy of Sciences. New University of Washington, was a winner of of Venezuela, have been elected to the members are Philip A. Beachy,The Johns the 2002 Gairdner Foundation International Academia de Ciencias de América Latina, Hopkins University School of Medicine; Award. The award recognizes individuals for the Latin American Academy of Sciences. Patrick O. Brown, Stanford University; their achievement in the field of medical Carlos J. Bustamante,University of Califor- science. He received the award, according to Robert J. Lefkowitz, an hhmi investigator at nia, Berkeley; Constance L. Cepko,Harvard the Foundation, for “his contributions to Duke University Medical Center, received Medical School; Jennifer A. Doudna,who development of the computational tools the 2002 Pasarow Award for Cardiovascular recently moved to the University of Cali- essential for sequencing of the human Research from the Robert J. and Claire fornia, Berkeley; Charles T. Esmon, Okla- genome. Further, he provided compelling Pasarow Foundation. homa Medical Research Foundation; early evidence for a dramatically reduced Richard A. Flavell,Yale University School of number of human genes.” ■ Richard P. Lifton, an hhmi investigator at Medicine; and Thomas Südhof,University of Yale University School of Medicine, won the Texas Southwestern Medical Center at Dal- ■ hhmi’s Holiday Lectures on Science,an American Society of Hypertension’s 2002 las. Thomas M. Jessell,Columbia University annual Webcast educational program pre- Richard Bright Award. College of Physicians and Surgeons, is a sented by hhmi investigators for high new foreign associate. school students, won two national awards ■ Richard M. Locksley, an hhmi investiga- for the 2001 lectures by hhmi investigators tor at the University of California, San ■ Three hhmi investigators, Pamela Bjork- David C. Page,Whitehead Institute for Bio- Francisco, is one of five new members man,California Institute of Technology, medical Research at the Massachusetts named to the National Advisory Allergy Judith Kimble,University of Wisconsin– Institute of Technology, and Barbara J. and Infectious Diseases Council, the prin- Madison, and Stanley J. Korsmeyer, Dana- Meyer,University of California,
Recommended publications
  • Parasite Epidemiology and Control
    PARASITE EPIDEMIOLOGY AND CONTROL AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.4 ISSN: 2405-6731 DESCRIPTION . Parasite Epidemiology and Control is an Open Access journal. There is increased parasitology research that analyses the patterns, causes, and effects of health and disease conditions in defined populations. This epidemiology of parasite infectious diseases is predominantly studied in human populations but also includes other major hosts of parasitic infections and as such this journal has broad remit. Parasite Epidemiology and Control focuses on the major areas of epidemiological study including disease etiology, disease surveillance, drug resistance, geographical spread, screening, biomonitoring, and comparisons of treatment effects in clinical trials for both human and other animals. We also focus on the epidemiology and control of vector insects. The journal also covers the use of geographic information systems (Epi-GIS) for epidemiological surveillance which is a rapidly growing area of research in infectious diseases. Molecular epidemiological approaches are also particularly encouraged. ABSTRACTING AND INDEXING . PubMed Central Directory of Open Access Journals (DOAJ) Google Scholar ScienceDirect Scopus EDITORIAL BOARD . Founding Editor Marcel Tanner, Swiss Tropical and Public Health Institute, Basel, Switzerland Epidemiology and control, health systems, one-health, global public health Editors Uwemedimo Friday Ekpo, Federal
    [Show full text]
  • Nobel Laureates Endorse Joe Biden
    Nobel Laureates endorse Joe Biden 81 American Nobel Laureates in Physics, Chemistry, and Medicine have signed this letter to express their support for former Vice President Joe Biden in the 2020 election for President of the United States. At no time in our nation’s history has there been a greater need for our leaders to appreciate the value of science in formulating public policy. During his long record of public service, Joe Biden has consistently demonstrated his willingness to listen to experts, his understanding of the value of international collaboration in research, and his respect for the contribution that immigrants make to the intellectual life of our country. As American citizens and as scientists, we wholeheartedly endorse Joe Biden for President. Name Category Prize Year Peter Agre Chemistry 2003 Sidney Altman Chemistry 1989 Frances H. Arnold Chemistry 2018 Paul Berg Chemistry 1980 Thomas R. Cech Chemistry 1989 Martin Chalfie Chemistry 2008 Elias James Corey Chemistry 1990 Joachim Frank Chemistry 2017 Walter Gilbert Chemistry 1980 John B. Goodenough Chemistry 2019 Alan Heeger Chemistry 2000 Dudley R. Herschbach Chemistry 1986 Roald Hoffmann Chemistry 1981 Brian K. Kobilka Chemistry 2012 Roger D. Kornberg Chemistry 2006 Robert J. Lefkowitz Chemistry 2012 Roderick MacKinnon Chemistry 2003 Paul L. Modrich Chemistry 2015 William E. Moerner Chemistry 2014 Mario J. Molina Chemistry 1995 Richard R. Schrock Chemistry 2005 K. Barry Sharpless Chemistry 2001 Sir James Fraser Stoddart Chemistry 2016 M. Stanley Whittingham Chemistry 2019 James P. Allison Medicine 2018 Richard Axel Medicine 2004 David Baltimore Medicine 1975 J. Michael Bishop Medicine 1989 Elizabeth H. Blackburn Medicine 2009 Michael S.
    [Show full text]
  • 2004 Albert Lasker Nomination Form
    albert and mary lasker foundation 110 East 42nd Street Suite 1300 New York, ny 10017 November 3, 2003 tel 212 286-0222 fax 212 286-0924 Greetings: www.laskerfoundation.org james w. fordyce On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination Chairman neen hunt, ed.d. for the 2004 Albert Lasker Medical Research Awards. President mrs. anne b. fordyce The Awards will be offered in three categories: Basic Medical Research, Clinical Medical Vice President Research, and Special Achievement in Medical Science. This is the 59th year of these christopher w. brody Treasurer awards. Since the program was first established in 1944, 68 Lasker Laureates have later w. michael brown Secretary won Nobel Prizes. Additional information on previous Lasker Laureates can be found jordan u. gutterman, m.d. online at our web site http://www.laskerfoundation.org. Representative Albert Lasker Medical Research Awards Program Nominations that have been made in previous years may be updated and resubmitted in purnell w. choppin, m.d. accordance with the instructions on page 2 of this nomination booklet. daniel e. koshland, jr., ph.d. mrs. william mccormick blair, jr. the honorable mark o. hatfied Nominations should be received by the Foundation no later than February 2, 2004. Directors Emeritus A distinguished panel of jurors will select the scientists to be honored. The 2004 Albert Lasker Medical Research Awards will be presented at a luncheon ceremony given by the Foundation in New York City on Friday, October 1, 2004. Sincerely, Joseph L. Goldstein, M.D. Chairman, Awards Jury Albert Lasker Medical Research Awards ALBERT LASKER MEDICAL2004 RESEARCH AWARDS PURPOSE AND DESCRIPTION OF THE AWARDS The major purpose of these Awards is to recognize and honor individuals who have made signifi- cant contributions in basic or clinical research in diseases that are the main cause of death and disability.
    [Show full text]
  • EMBC Annual Report 2007
    EMBO | EMBC annual report 2007 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION | EUROPEAN MOLECULAR BIOLOGY CONFERENCE EMBO | EMBC table of contents introduction preface by Hermann Bujard, EMBO 4 preface by Tim Hunt and Christiane Nüsslein-Volhard, EMBO Council 6 preface by Marja Makarow and Isabella Beretta, EMBC 7 past & present timeline 10 brief history 11 EMBO | EMBC | EMBL aims 12 EMBO actions 2007 15 EMBC actions 2007 17 EMBO & EMBC programmes and activities fellowship programme 20 courses & workshops programme 21 young investigator programme 22 installation grants 23 science & society programme 24 electronic information programme 25 EMBO activities The EMBO Journal 28 EMBO reports 29 Molecular Systems Biology 30 journal subject categories 31 national science reviews 32 women in science 33 gold medal 34 award for communication in the life sciences 35 plenary lectures 36 communications 37 European Life Sciences Forum (ELSF) 38 ➔ 2 table of contents appendix EMBC delegates and advisers 42 EMBC scale of contributions 49 EMBO council members 2007 50 EMBO committee members & auditors 2007 51 EMBO council members 2008 52 EMBO committee members & auditors 2008 53 EMBO members elected in 2007 54 advisory editorial boards & senior editors 2007 64 long-term fellowship awards 2007 66 long-term fellowships: statistics 82 long-term fellowships 2007: geographical distribution 84 short-term fellowship awards 2007 86 short-term fellowships: statistics 104 short-term fellowships 2007: geographical distribution 106 young investigators 2007 108 installation
    [Show full text]
  • 2019 Annual Report
    BECKMAN CENTER 279 Campus Drive West Stanford, CA 94305 650.723.8423 Stanford University | Beckman Center 2019 Annual Report Annual 2019 | Beckman Center University Stanford beckman.stanford.edu 2019 ANNUAL REPORT ARNOLD AND MABEL BECKMAN CENTER FOR MOLECULAR AND GENETIC MEDICINE 30 Years of Innovation, Discovery, and Leadership in the Life Sciences CREDITS: Cover Design: Neil Murphy, Ghostdog Design Graphic Design: Jack Lem, AlphaGraphics Mountain View Photography: Justin Lewis Beckman Center Director Photo: Christine Baker, Lotus Pod Designs MESSAGE FROM THE DIRECTOR Dear Friends and Trustees, It has been 30 years since the Beckman Center for Molecular and Genetic Medicine at Stanford University School of Medicine opened its doors in 1989. The number of translational scientific discoveries and technological innovations derived from the center’s research labs over the course of the past three decades has been remarkable. Equally remarkable have been the number of scientific awards and honors, including Nobel prizes, received by Beckman faculty and the number of young scientists mentored by Beckman faculty who have gone on to prominent positions in academia, bio-technology and related fields. This year we include several featured articles on these accomplishments. In the field of translational medicine, these discoveries range from the causes of skin, bladder and other cancers, to the identification of human stem cells, from the design of new antifungals and antibiotics to the molecular underpinnings of autism, and from opioids for pain
    [Show full text]
  • Date: To: September 22, 1 997 Mr Ian Johnston©
    22-SEP-1997 16:36 NOBELSTIFTELSEN 4& 8 6603847 SID 01 NOBELSTIFTELSEN The Nobel Foundation TELEFAX Date: September 22, 1 997 To: Mr Ian Johnston© Company: Executive Office of the Secretary-General Fax no: 0091-2129633511 From: The Nobel Foundation Total number of pages: olO MESSAGE DearMrJohnstone, With reference to your fax and to our telephone conversation, I am enclosing the address list of all Nobel Prize laureates. Yours sincerely, Ingr BergstrSm Mailing address: Bos StU S-102 45 Stockholm. Sweden Strat itddrtSMi Suircfatan 14 Teleptelrtts: (-MB S) 663 » 20 Fsuc (*-«>!) «W Jg 47 22-SEP-1997 16:36 NOBELSTIFTELSEN 46 B S603847 SID 02 22-SEP-1997 16:35 NOBELSTIFTELSEN 46 8 6603847 SID 03 Professor Willis E, Lamb Jr Prof. Aleksandre M. Prokhorov Dr. Leo EsaJki 848 North Norris Avenue Russian Academy of Sciences University of Tsukuba TUCSON, AZ 857 19 Leninskii Prospect 14 Tsukuba USA MSOCOWV71 Ibaraki Ru s s I a 305 Japan 59* c>io Dr. Tsung Dao Lee Professor Hans A. Bethe Professor Antony Hewlsh Department of Physics Cornell University Cavendish Laboratory Columbia University ITHACA, NY 14853 University of Cambridge 538 West I20th Street USA CAMBRIDGE CB3 OHE NEW YORK, NY 10027 England USA S96 014 S ' Dr. Chen Ning Yang Professor Murray Gell-Mann ^ Professor Aage Bohr The Institute for Department of Physics Niels Bohr Institutet Theoretical Physics California Institute of Technology Blegdamsvej 17 State University of New York PASADENA, CA91125 DK-2100 KOPENHAMN 0 STONY BROOK, NY 11794 USA D anni ark USA 595 600 613 Professor Owen Chamberlain Professor Louis Neel ' Professor Ben Mottelson 6068 Margarldo Drive Membre de rinstitute Nordita OAKLAND, CA 946 IS 15 Rue Marcel-Allegot Blegdamsvej 17 USA F-92190 MEUDON-BELLEVUE DK-2100 KOPENHAMN 0 Frankrike D an m ar k 599 615 Professor Donald A.
    [Show full text]
  • Plasmodium Falciparum BMC Biology, 2015; 13(1):52-1-52-19
    PUBLISHED VERSION Danny W Wilson, Christopher D Goodman, Brad E Sleebs, Greta E Weiss, Nienke WM de Jong, Fiona Angrisano, Christine Langer, Jake Baum, Brendan S Crabb, Paul R Gilson, Geoffrey I McFadden, and James G Beeson Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum BMC Biology, 2015; 13(1):52-1-52-19 © 2015 Wilson et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Originally published at: http://doi.org/10.1186/s12915-015-0162-0 PERMISSIONS http://creativecommons.org/licenses/by/4.0/ http://hdl.handle.net/2440/93434 Wilson et al. BMC Biology (2015) 13:52 DOI 10.1186/s12915-015-0162-0 RESEARCH ARTICLE Open Access Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum Danny W Wilson1,2,3,4*, Christopher D Goodman5, Brad E Sleebs2,3, Greta E Weiss4, Nienke WM de Jong4, Fiona Angrisano2,3,6, Christine Langer4, Jake Baum2,3,6, Brendan S Crabb3,4,7, Paul R Gilson4,7, Geoffrey I McFadden5 and James G Beeson2,4,8* Abstract Background: Malaria invasion of red blood cells involves multiple parasite-specific targets that are easily accessible to inhibitory compounds, making it an attractive target for antimalarial development.
    [Show full text]
  • 2007 Keio Medical Science Prize Winner Announcement
    FOR IMMEDIATE RELEASE http://www.keio.ac.jp/ September 26, 2007 2007 Keio Medical Science Prize Winner Announcement Keio University presents the “Keio Medical Science Prize” to researchers in recognition of their outstanding achievements in the fields of medical or life sciences. It is the only prize of its kind to be awarded by a Japanese university. The 12th Keio Medical Science Prize will be awarded to Dr. Brian J. Druker and Dr. Hiroaki Mitsuya. Brian J. Druker, M.D. Investigator, Howard Hughes Medical Institute Director, Oregon Health & Science University Cancer Institute JELD-WEN Chair of Leukemia Research For the development of a molecular-targeted drug for chronic myelogenous leukemia Hiroaki Mitsuya, M.D., Ph.D. Professor, Department of Hematology, Department of Rheumatology and Clinical Immunology, Division of Infections Diseases, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University Chief and Principal Investigator, Experimental Retrovirology Section Center for Cancer Research National Cancer Institute For the development of anti-AIDS drugs Award Ceremony and Commemorative Symposium The award ceremony and a commemorative lecture given by the prize winners will be held on December 4, 2007 and a commemorative symposium will take place on December 5. Both events will be held at the Keio University School of Medicine (Shinanomachi Campus). Please see the contact information below to inquire about interviews or photographs. Attachments : (1) About the Keio University Medical Science Fund (2)2007 Prize Winner: Brian J. Druker(Theme, CV, other information) (3)2007 Prize Winner: Hiroaki Mitsuya(Theme, CV, other information) (4)2007 Keio Medical Science Prize Award Ceremony/Commemorative Lecture/ Commemorative Symposium Inquiries: Keio University Medical Science Fund(Ms.
    [Show full text]
  • Editorial Advisory Board Editor-In-Chief: Alanna Schepartz Associate Editors Executive Editors Managing Editor
    EDITOR-IN-CHIEF: ALANNA SCHEPARTZ Yale University Department of Chemistry Department of Molecular, Cellular, and Developmental Biology [email protected] EXECUTIVE EDITORS Nathanael Gray Linda Hsieh-Wilson Hongwei Wang Harvard University Medical School California Institute of Technology Tsinghua University [email protected] [email protected] [email protected] ASSOCIATE EDITORS Ulrike Eggert Farren Isaacs King’s College London Yale University [email protected] [email protected] Jayant B. Udgaonkar John A. Gerlt National Centre for Biological Sciences, University of Illinois, Urbana-Champaign Tata Institute of Fundamental Research [email protected] [email protected] MANAGING EDITOR Alyson Weidmann [email protected] EDITORIAL ADVISORY BOARD Natalie G. Ahn Masao Ikeda-Saito Daniela Rhodes University of Colorado, Boulder Tohoku University Nanyang Technological University Johan Aqvist Matthew P. Jacobson Marina Rodnina Uppsala University California Institute for Quantitative Biosciences Max Planck David S. Auld Amy Rosenzweig Dan Kahne Harvard Medical School Northwestern Harvard Nenad Ban Jamie Rossjohn ETH Zurich Lewis E. Kay Monash University University of Toronto Dorothy Beckett Bryan Roth University of Maryland Peter S. Kim UNC Chapel Hill Stephen J. Benkovic Stanford University Mark Sansom The Pennsylvania State University Judith P. Klinman University of Oxford Carolyn Bertozzi University of California, Berkeley Harold A. Scheraga Stanford Elizabeth Komives Cornell University Robert E. Blankenship University of California, San Diego Yunyu Shi Washington University in St. Louis University of Science & Technology of China John W. Kozarich David F. Bocian Stephan Sieber ActivX Biosciences, Inc. University of California, Riverside Technical University of Munich Gary Brudvig John D.
    [Show full text]
  • 2020 Annual Report
    2020 Annual Report Make this cover come alive with augmented reality. Details on inside back cover. Contents The Walter and Eliza Hall Institute About WEHI 1 of Medical Research President’s report 2 Parkville campus 1G Royal Parade Director’s report 3 Parkville Victoria 3052 Australia Telephone: +61 3 9345 2555 WEHI’s new brand launched 4 Bundoora campus 4 Research Avenue Our supporters 10 La Trobe R&D Park Bundoora Victoria 3086 Australia Exceptional science and people 13 Telephone: +61 3 9345 2200 www.wehi.edu.au 2020 graduates 38 WEHIresearch Patents granted in 2020 40 WEHI_research WEHI_research WEHImovies A remarkable place 41 Walter and Eliza Hall Institute Operational overview 42 ABN 12 004 251 423 © The Walter and Eliza Hall Institute Expanding connections with our alumni 45 of Medical Research 2021 Diversity and inclusion 46 Produced by the WEHI’s Communications and Marketing department Working towards reconciliation 48 Director Organisation and governance 49 Douglas J Hilton AO BSc Mon BSc(Hons) PhD Melb FAA FTSE FAHMS WEHI Board 50 Deputy Director, Scientific Strategy WEHI organisation 52 Alan Cowman AC BSc(Hons) Griffith PhD Melb FAA FRS FASM FASP Members of WEHI 54 Chief Operating Officer WEHI supporters 56 Carolyn MacDonald BArts (Journalism) RMIT 2020 Board Subcommittees 58 Chief Financial Officer 2020 Financial Statements 59 Joel Chibert BCom Melb GradDipCA FAICD Financial statements contents 60 Company Secretary Mark Licciardo Statistical summary 94 BBus(Acc) GradDip CSP FGIA FCIS FAICD The year at a glance 98 Honorary
    [Show full text]
  • Precision Cancer Medicine: Achievements and Prospects
    Precision Cancer Medicine: Achievements and Prospects John Mendelsohn, MD President Emeritus Tang Prize Award Ceremony September 22, 2018 Presented by Mien-Chie Hung, PhD Dr. John Mendelsohn with M.D. Anderson’s Hospital Education • Harvard College, Cambridge, MA, B.A., 1958, Biochemical Science • University of Glasgow, Glasgow, Scotland, Fulbright Scholar, 1959, Research in Molecular Biology • Harvard Medical School, M.D. 1963 Academic Administrative Appointments/Responsibilities •Founding Director of Cancer Center, University of California, San Diego, CA, 1976-85 •Chairman, Department of Medicine, Memorial Sloan- Kettering Cancer Center, New York, NY, 1985-96 •President, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1996- 2011 •Director, Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2011-18 Scientific Achievements • First hypothesis, with Dr. Gordon Sato, that inhibition of EGF receptors and of a tyrosine kinase might be an effective anticancer treatment. 1980 • First creation of an anti-EGF receptor/anti-tyrosine kinase agent that blocked receptor kinase activation and inhibited cell growth. 1983-84 • First clinical trial with an agent targeting a growth factor receptor and a tyrosine kinase, demonstrating safety and feasibility. 1990 • First studies demonstrating mechanisms by which inhibition of EGF receptor tyrosine kinase inhibits cell proliferation and other cellular functions. 1996 • First clinical trial providing proof of concept that an antireceptor agent (Herceptin) used alone could produce a clinically useful response rate (10%) in patients. 1996 • First clinical trial demonstrating that addition of an EGF receptor inhibitor could overcome resistance to a chemotherapeutic agent (cisplatin in head and neck cancer).
    [Show full text]
  • Milestones in Oncology: Events That Changed the Course of Cancer Therapy and Implications for the Future
    Milestones in Oncology: Events that Changed the Course of Cancer Therapy and Implications for the Future ,, .. Milestones in Oncology: Events that Changed the Course of Cancer Therapy and Implications for the Future Target Audience Continuing Pharmaceutical Education The target audience for this complimentary activity is medical 1.25 contact hours (.125 CEUs) of credit for oncologists, hematologists, oncology nurses, and pharmacists. pharmacists. Approval of this course for pharmacists is under a cosponsorship agreement between The American School of Oncology and Medical Education Program Overview Collaborative, Inc. MEC is accredited by the Accreditation This is an exciting and thought-provoking overview of a few of Council for Pharmacy Education as a provider of continuing the milestones in the development of cancer therapy as we know pharmacy education. ACPE # 815-999-07-039-H01. The it today. Several knowledgeable scientists and practitioners program is designed for all pharmacists. who are considered foremost international experts describe the evolution of oncology as a specialty and advancements made in the cure of, as well as management of, a multitude of cancers. Continuing Nursing Education Included in the monograph are discussions on the development Medical Education Collaborative, Inc. is accredited as a provider of curative therapy for Hodgkin disease, testicular cancer, of continuing nursing education by the American Nurses as well as advancements in the treatment of chronic myeloid Credentialing Center’s Commission on Accreditation. leukemia, non-small cell lung cancer, head and neck cancer, and breast cancer. Timelines are presented to indicate the amazing RNs, LPNs, LVNs, and NPs can receive up to 1.25 contact hours evolution of clinical trials and the discoveries of a number of for participation in this program.
    [Show full text]